Meningiomas linked to the Depo-Provera birth control shot often form at the base of the skull, where complete removal is difficult and tumors are more likely to return. This post explains Simpson grades, how recurrent meningiomas are treated, and why women whose tumors came back after surgery may still qualify to file a Depo-Provera lawsuit.
Many women diagnosed with meningioma after long-term Depo-Provera use have more than one brain tumor, often at the base of the skull. This post explains what recent studies found, how Gamma Knife, CyberKnife, and craniotomy are used to treat multiple meningiomas, and who may qualify to file a Depo-Provera lawsuit and receive compensation.
Some meningioma brain tumors linked to the Depo-Provera birth control shot shrink or stop growing after women stop receiving injections, according to studies published in 2025 and 2026. This post explains what the research found, why some tumors still require treatment, and why women whose tumors shrank or never required surgery may still qualify to file a Depo-Provera lawsuit.
Pfizer reached a Master Settlement Agreement in June 2026 to resolve many Depo-Provera meningioma lawsuits, and registration is expected to be completed in November 2026. The settlement program is designed for women whose cases are already pending. Women diagnosed with meningioma after using the Depo shot who have not yet filed a Depo-Provera lawsuit may still qualify to take legal action.
Meningioma brain tumors are removed through very different operations. This post explains craniotomy, skull base approaches, keyhole and endonasal surgery, preoperative embolization, and partial removal, along with recovery risks and what surgical records prove about damages in a Depo-Provera lawsuit.
Women diagnosed with a meningioma brain tumor after using the Depo-Provera birth control shot are often treated with radiation instead of surgery. This post explains Gamma Knife, CyberKnife, fractionated radiotherapy, IMRT, and proton therapy, and how radiation treatment affects eligibility and claim value in a Depo-Provera lawsuit.
Women diagnosed with meningioma after using Depo-Provera often assume that only those who underwent brain surgery can file. Treatment choice does not decide eligibility. This post explains craniotomy and CyberKnife radiosurgery, how doctors choose between them, and how treatment history affects the value of a Depo-Provera lawsuit.
Many women who used the Depo-Provera birth control shot assume that a benign meningioma means they have no legal claim. That assumption is wrong. Tumors described as benign or WHO Grade I still require brain surgery, radiation, and years of monitoring. Women diagnosed after using the Depo shot may be eligible to file a lawsuit.
Women diagnosed with meningioma after using the Depo-Provera birth control shot may qualify for compensation. This post explains why no fixed payout exists, the factors that affect claim value, and where the June 2026 Pfizer settlement stands. Learn more about filing a Depo-Provera lawsuit with Hissey Mulderig & Friend.
Women diagnosed with meningioma brain tumors after using Depo-Provera may qualify to recover compensation for medical bills, lost income, and pain and suffering. Learn what damages may be available in a Depo-Provera lawsuit, what factors affect the value of a claim, and how the June 2026 settlement may affect your legal options.
